This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Diamandis E, Fritsche HA, Lilja H et al (2002) Tumor markers. Physiology, pathobiology, technology, and clinical applications, 1. Aufl. AACC Press, Washington, DC
Hardt PD, Mazurek S, Toepler M et al (2004) Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer 91:980–984
Haug U, Hundt S, Brenner H (2008) Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study. British Journal of Cancer 99 (1):133–135
Yogesh MS, Stefan L, Nicolas H, Nada P, Ernst H, Wolfgang R, Joachim M, Jürgen MS (2008) Comparison of an Established Simple Office-Based Immunological FOBT With Fecal Tumor Pyruvate Kinase Type M2 (M2-PK) for Colorectal Cancer Screening: Prospective Multicenter Study. The American Journal of Gastroenterology 103 (6):1496–1504
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Holdenrieder, S., Stieber, P. (2019). Tumor-M2-Pyruvatkinase. In: Gressner, A.M., Arndt, T. (eds) Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48986-4_3134
Download citation
DOI: https://doi.org/10.1007/978-3-662-48986-4_3134
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48985-7
Online ISBN: 978-3-662-48986-4
eBook Packages: Medicine (German Language)